Accel-backed Portea Medical to provide ICU services at home

The cost of treatment for the patient will come down between a third and a fifth through critical home care services, the company said

Home healthcare services provider Portea Medical has expanded its services and forayed into specialised and critical home care. The suite of services also includes end of life care for terminally ill patients.

Since the critical care market is pegged at $500 million, the company backed by investors such as Accel, Qualcomm Ventures, and Sabre Partners, would be further extending the services to chemotherapy-from-home and dialysis-from-home in the near future.

“Many patients who are in intensive care do not require active intervention. All that needs to be done is to keep them stable and monitor them. In such a scenario, for